Page 971«..1020..970971972973..980990..»

A Kingdom of Care: Regenics Wellness Center and Its Groundbreaking Services – PRNewswire

Posted: June 15, 2020 at 10:47 pm

LOS ANGELES, June 15, 2020 /PRNewswire/ --The health services economy is witnessingthe flow of over a trillion dollars every year. In a booming industry that is growing at a steep rate, companies are scrambling to get ahead of the game. By providing more cutting-edge technology, client-friendly atmospheres, and competitive prices, medical practices are working every angle to climb to the top. In our modern society, customers crave new experiences and constant upgrades to their care. An up-and-coming brand,Regenicsis here to provide just that.

Regenics is a rising wellness center with its business centered around hormone balancing and regenerative health. Regenicshas broken into the health industry with a full-spectrum approach to supplementary care. Offering meal and fitness planning, BMI testing, IV therapy, vitamins and supplements, cryotherapy, and CBD products, the company is primarily geared towards men's health - specifically testosterone deficiency. Their team is on a mission to erase the stigma surrounding testosterone replacement therapy, as well as shed light on the current misconceptions of the treatment. Regenicsis staying ahead of the health services game by making their patients and clients feel welcome, ordinary, and safe with their treatment - pioneeringthe normalization of thesetreatments.

Another element that makes Regenics so unique is its futuristic, vibrant, and eye-catching image. Take a trip to their social media pages, home to a following over 50,000 strong, and you'll find posts featuring men and women sporting Regenics gear who look like they've popped straight out of Sports Illustrated ads. On top of that, Regenics has branded itself with a graphic logo that is clean, simple, and wearable. But most importantly, their executives have decided to reshape the medical facility arena - with the idea to be home to a medical center without the eerie and bare medical feel. Regenics has created a more inviting physical environment for their clients while still providing a host of certified medical treatments and products. Striving to make their company one-of-a-kind in the customer service game, Regenics executives have concentrated much of their time on their approachable and impressive "ideal shape" image.

Regenics also takes the edge over its competitors because of its efforts to offer a full-scale service to restore the body's supplementary needs on a molecular level. Advertised and fulfilled as a top-of-the-line service, Regenics tackles all aspects of personal well-being - mental, physical, spiritual, and financial. In a competitive industry with such large cash and customer flow, it is only with this uncommon combination of products, services, and approaches to health that companies like Regenics begin to dominate the arena.

While geared towards men in their middle ages, Regenics has a little bit of something for everyone. Whether you're looking for elite athletic care, calming medicinal CBD, or other supplementary and regenerative treatment, this is the place for you.

Contact:Daniel Ortiz[emailprotected]

Related Images

regenics-iv-lounge.jpg Regenics IV Lounge A client receives an IV Infusion at Regenic's IV Lounge.

Related Links

IV Infusion

Cryotherapy

SOURCE Regenics

See the article here:
A Kingdom of Care: Regenics Wellness Center and Its Groundbreaking Services - PRNewswire

Posted in Hormone Replacement Therapy | Comments Off on A Kingdom of Care: Regenics Wellness Center and Its Groundbreaking Services – PRNewswire

JK Rowling falsely claims an ‘explosion’ of girls have de-transitioned – Insider – INSIDER

Posted: June 15, 2020 at 10:47 pm

J.K. Rowling, author of the beloved "Harry Potter" series, published a lengthy blog post on her website this week, attempting to explain her controversial tweets about transgender women.

The author has been widely criticized for a history of making transphobic comments, including most recently writing on Twitter that trans activism was harming women, and reiterating her rejection of the existence of non-binary and intersex people.

Rowling said in her post that one of the reasons she's taken such positions is that she's "concerned about the huge explosion in young women wishing to transition," as well as the growing number who she says seem to be detransitioning, or returning to the sex they were assigned at birth.

They do so, Rowling wrote, "because they regret taking steps that have, in some cases, altered their bodies irrevocably, and taken away their fertility."

She added: "Some say they decided to transition after realizing they were same-sex attracted, and that transitioning was partly driven by homophobia, either in society or in their families."

Rowling also said that 10 years ago most people who wanted to transition were assigned male at birth, but now the UK "has experienced a 4,400% increase in girls being referred for transitioning treatment," adding that autistic girls are "hugely overrepresented."

Rowling's claims are not only unsupported by data, but perpetuate dangerous myths about trans people that can inhibit their access to life-saving care.

Demographers don't know exactly how many transgender people there are or how that number has changed, since there are a range of terms to describe transgender identities and population-based surveys have historically not asked about trans identities.

Rowling's 4,400% increase reference seems to come from a report finding that 40 people assigned female at birth in the UK sought gender treatment between 2009 and 2010, while 1,806 did between 2017 and 2018.

Polly Carmichael, a psychologist who heads The Tavistock and Portman mental health clinic's gender identity service (which was the only trans affirming service in the UK in 2016), told NBC that while she is seeing large increase in the number of patients in need of gender-affirming care, this is likely due to an increase in visibility for trans services and gender varience rather than a "trend."

"Young people experiencing gender dysphoria is a real phenomenon," Carmichael said. "It can be incredibly isolating. If you don't feel you belong in a particular category that you've been assigned to. Many adolescents do become very distressed and self-harm."

Rowling's assertion that being a trans boy or man is suddenly more common than being a trans girl or woman is also questionable. In fact, one 2019 survey from the UK government found 3.5% of the population were trans women (women who were assigned male at birth) while 2.9% were trans men (men who'd been assigned female at birth).

In this Aug. 23, 2007 file photo, a sign marks the entrance to a gender neutral restroom at the University of Vermont in Burlington, Vt. AP Photo/Toby Talbot, File

While more people who were assigned female at birth have transitioned in recent years, that's likely because gender-affirming treatments such as hormone replacement therapy (HRT) and surgeries weren't that accessible to transgender people until recently.

Insurance companies refused to cover gender-affirming care for decades and many primary-care physicians were unwilling to provide HRT, a medication also prescribed for menopause, to transgender and nonbinary patients because medical guidelines had not changed to include them.

It wasn't until 2017 that "gender identity disorder" was decategorized as a mental disorder in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders. In fact the World Health Organization removed "transsexualism" from the International Classification of Diseases only in 2018 a move that, the WHO said, would allow for better "access to necessary health interventions."

Many trans people simply have more access.

While detransitioning does happen, it's very rare, with one analysis showing that less than a percent of 3,398 trans people said they'd experienced transitioned-related regret, or had detransitioned.

And contrary to Rowling's assertion that detransitioning means the person regretted transitioning, "the most common reason for detransition is the person couldn't cope with the family and community support they lost and the experiences of transphobia," according to the UK organization Stonewall.

Others may be unable to find a job or housing, or no longer identify the gender they transitioned to feel more valid in.

Research actually shows any feelings of regret are typically related to unsatisfactory surgical results.

Getty/Angela Weiss

These fears about detransitioning can be dangerous because they invalidate the gender identities of young trans people and make it more difficult to obtain access to care.

Across the United States, state representatives are attempting to pass legislation that would go against medical guidelines and ban doctors from providing gender-affirming treatments to transgender youth. Their arguments are based on the same logic of Rowling's assertion that transgender youth are simply going through a phase they will grow out of.

Studies have debunked this idea and shown children as young as four develop their gender in the same ways as their cisgender peers.

In a study released in 2019, researchers found no significant differences between the trans and cis kids' gender development, or how they grew to understand and formulate their gender.The findings also revealed that transgender children gravitate toward the same gendered toys, clothing items, and friends as cisgender participants, regardless of how long they had been socially transitioned.

"Gender-affirming health care saves lives," Shawn Meerkamper and Dale Melchert, senior staff attorney and staff attorney for the Transgender Law Center, told Insider for a previous story.

Frank Franklin II/Associated Press

In her essay, Rowling made the point that the gender dysphoria when a person feels as if their body doesn't match their gender identity that many young trans people are feeling is a "social contagion."

She cited a 2018 study from Brown University that argued the "rapid-onset gender dysphoria" (ROGD), typically for those assigned female at birth, came out of social pressures from peers rather than genuine feelings of being transgender.

This study has since been cited by media outlets and gender-critical feminists as an argument against transgender youth receiving gender-affirming care. Like Rowling, people have used this research to make the argument that being trans is a trend.

However, another recent study from Brown University debunked the claim that ROGD exists.

Arjee Restar, a transgender researcher at Brown, wrote a critique of the study that found themethodology including surveying parents of trans teens who had read anti-trans websites is flawed and pathologizes trans people.

PLOS One, the journal the 2018 study appeared in, published a revised version that said the data was based on observations of parents rather than data from the trans teens themselves. If a parent does not see their child's gender identity as valid, they are likely more susceptible to cite ROGD as the reason their child has started to openly identify as trans.

Restar told BuzzFeed News that the corrected version of the study was still flawed and "below scientific standards."

"It's important to use methods and terminologies that don't further stigmatize an already disenfranchised community," Restar said.

Read More:

Trans 'Harry Potter' fans say they are devastated by JK Rowling's transphobia but some say it's a distraction from the violence against trans Black people

'Transgender women are women': Daniel Radcliffe rebukes J.K. Rowling's comments and apologizes to 'Harry Potter' readers if their experience of the books is now tarnished

People are sharing hormones on Google Docs and turning to 'grey market' pharmacies to get gender-affirming care during the pandemic

Read more here:
JK Rowling falsely claims an 'explosion' of girls have de-transitioned - Insider - INSIDER

Posted in Hormone Replacement Therapy | Comments Off on JK Rowling falsely claims an ‘explosion’ of girls have de-transitioned – Insider – INSIDER

Compounding Pharmacies Market Outlook and Opportunities in Grooming Regions Through 2025 – Personal Injury Bureau UK

Posted: June 15, 2020 at 10:47 pm

The change during the COVID-19 pandemic has upgraded our reliance on trend setting innovations, for example, augmented reality, virtual reality, and the industrial internet of things. The unfulfilled money related targets are convincing the associations to embrace robotization and cutting edge innovations to remain ahead in the market rivalry. Organizations are using this open door by distinguishing day by day operational needs and teaching robotization in it to make a computerized framework as long as possible.

According to the latest market report published by Persistence Market Research titledCompounding Pharmacies Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,the global compounding pharmacies market is expected to expand at a CAGR of 7.5% during the forecast period 2017-2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of key market participants. The globalcompounding pharmacies marketis projected to expand at a healthy CAGR of 7.5% in terms of value during the forecast period, revised from the previous CAGR of 4.4%, due to factors such as increasing medicinal droughts of prescription medicine across the globe, regarding which Persistence Market Research offers useful insights in detail in this report.

Request to Sample report @https://www.persistencemarketresearch.com/samples/19396

The primary factors driving revenue growth of the global compounding pharmacies market are increasing medicinal droughts of prescription medicine, growing demand for HRT drugs, and increase in demand for topical products these factors will upsurge the growth of the compounding pharmacies market in the coming years. Increasing restricted formulations and unsafe compounding practices are some of the factors that will restrain the growth of the compounding pharmacies market over the forecast period.

Segmental Forecast of the Global Compounding Pharmacies Market

The market is segmented based on product type, application type, therapeutic area and region. On the basis of product type the market has been segmented as oral medication, topical medication, mouthwashes and suppositories. By product type, the oral medication segment is expected to remain the largest segment, registering a CAGR of 9.5% in terms of value over the forecast period. The oral medication product type segment is expected to reach a market value of US$ 6,357.7 Mn by 2025 end.

On the basis of application type, the compounding pharmacies market has been segmented as

medication for adults, medication for veterinary, medication for children and medication for geriatric. The medication for adults segment is expected to remain the largest segment, registering a CAGR of 9.0% in terms of value over the forecast period. The medication for adults application type segment is expected to reach a market value of US$ 7,588.7 Mn by 2025 end.

Request For [emailprotected]https://www.persistencemarketresearch.com/methodology/19396

On the basis of therapeutic area, the compounding pharmacies market has been segmented as pain management and hormone replacement therapy. By therapeutic area, hormone replacement therapy is expected to remain the largest segment, registering a CAGR of 9.9% in terms of value over the forecast period. The hormone replacement therapy segment is expected to reach a market value of US$ 9,380.7 Mn by 2025 end.

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America dominated the global compounding pharmacies market with maximum value share of the overall market in 2016. The North America compounding pharmacies market is expected to register the highest CAGR of 7.6% over the forecast period to reach a market value of US$ 8,953.3 Mn by 2025 end.

Company Profiles

Our unmatched research methodologies set us apart from our competitors. Heres why:

For in-depth competitive analysis, buy [emailprotected]https://www.persistencemarketresearch.com/checkout/19396

Read more here:
Compounding Pharmacies Market Outlook and Opportunities in Grooming Regions Through 2025 - Personal Injury Bureau UK

Posted in Hormone Replacement Therapy | Comments Off on Compounding Pharmacies Market Outlook and Opportunities in Grooming Regions Through 2025 – Personal Injury Bureau UK

Coping with PMDD, the crippling period condition – cosmopolitan.com

Posted: June 15, 2020 at 10:47 pm

There used to be a running joke in my family. Are you due on? my mum would ask, a smile resting on her face. Shed say it after witnessing one of my many meltdowns. But I wasnt just snappy or bursting into tears at silly things, as so many of us do when our period is about to arrive. Instead, for over a decade, I was completely out of control of my own life and no one knew why. How could they when I didnt even know myself?

I had a loving family, good friends, a fulfilling career. I should have been happy. But I wasnt. The answer, it turns out, lay in Mums joke. My depression, anxiety, anorexia they were all down to one thing: my menstrual cycle. So why did it take 14 years and countless overdoses for that to be diagnosed?

It all started when I was 12. Up until that year, Id been a happy child, growing up in Derbyshire with my mum, dad and younger brother. But I started waking up with a dark cloud over my head. Intrusive thoughts would flood my brain, hardening into an ongoing sense of panic and foreboding. Then there were the physical symptoms: headaches, insomnia and a lethargy that made my bones feel like they were made of concrete. There was just one respite: for five days of the month, I felt fine, like my old self again. Laughing with my friends and family, Id think, Im back. But that didnt last for long.

My teenage years passed in a blur. I was a voyeur, looking into the fishbowl of my life and watching from the outside as everyone had fun without me. I felt cocooned by a feeling of worthlessness. Failure terrified me my A-levels filled me with such extreme anxiety I would have panic attacks just thinking about them. Sitting in lessons, the words I cant do this swirled in front of me until I had to run out of class, hyperventilating. Id spend all my free time studying, to catch up on what Id missed, instead of hanging out with friends or dating. I was lonely. Anxious. I hated my life.

"It was like Id lost every ounce of control. I didnt want to die I just wanted a break from the anxiety and worthlessness that plagued me."

I visited doctor after doctor and was diagnosed with chronic fatigue syndrome, then anxiety, then depression, then anorexia. I was anorexic. I would exercise like crazy every lunchtime and after school, running until I burned myself out. But, looking back, it was clear I was searching for control anywhere I could get it.

When I got a place at the University of Southampton to study physiotherapy, I saw it as a way to escape. I thought perhaps if I moved away from home, my problems would go away too. But despite making friends and forcing myself to go along to parties, I sank even deeper into the darkness. One day I found myself sitting on a park bench, taking an overdose. It was like Id lost every ounce of control. I didnt want to die I just wanted a break from the anxiety and worthlessness that plagued me. When I woke up, I was in hospital. I had no idea how I got there. My thoughts went straight to my family. How could I do that to them?

But my remorse didnt last for long. Soon overdosing became a regular part of my life never to end it, but because I needed the unexplained chaos within my mind and body to stop. There were even times I wished someone would put me into a coma, so that I was still alive but didnt have to think or feel. I craved numbness.

Eventually I was allocated a crisis team and put under observation. This heightened awareness around me only made me even more secretive about what I was doing. My friends became used to watching my decline, but I hid the worst from them, overdosing in private. There were times Id wake up alone in a panic and call the crisis team whod sometimes send an ambulance to bring me in for treatment. My friends begged me to stop. I wouldnt listen. I was convinced I wasnt worth their worry.

One day my mum came to surprise me at my flat. She found me mid-overdose, curled up like a little mouse in the corner of my room. I dont remember much about that day only that my mum was absolutely heartbroken. But the guilt I felt didnt stop me. Throughout my final year, I was admitted to hospital for overdosing a further three times, all without my parents knowledge.

Despite all of this, I was determined to pass my university course. Driven by a fear of failure, I rewrote my final essay five times, staying up for nights on end without sleeping. I graduated in 2012, landing a full-time job that was a 30-minute drive away from my family, and moving into a house-share with a stranger. I loved my work so much that I refused to miss even one day of it but outside of that, I was crumbling. Three years into the role, my anorexia was so bad that I was malnourished and I couldnt do my job properly, so my managers and I agreed I would take leave indefinitely. After that, my mum became my full-time carer, cooking me meals that Id tentatively push around my plate, rationing out my medication to make sure I didnt take too much, and going out with me for walks. It felt like my life was on pause.

Around this time, my doctor began to notice something. Id been seeing her for the past year and she was unlike any other medical professional Id met. However bad things became, she always believed I had the strength to get past them. Through my regular visits, she began to pick up on some patterns: how I always seemed to be at my worst the day before my period was due. She thought I could have something called premenstrual dysphoric disorder, or PMDD. I had never heard of it. Put simply, PMDD is like PMS Extra, and affects around 5.5% of women, driving around 30% of sufferers to attempt suicide. Starting, on average, at around the time of ovulation and usually ending when a period arrives around two weeks later, the symptoms can include extreme anxiety, psychosis, depression and, at worst, wanting to harm yourself and others. Unlike PMS, PMDD can be so debilitating that work, social life and relationships may become impossible to manage for more than a few days a month. The cause is not yet clear, but its thought that people with PMDD are more sensitive to the hormonal changes that come with your cycle.

At first I thought the idea was silly: surely there was no way that a period could have this much impact? But over the years, Id been tracking my menstrual cycle on a calendar and writing about my mental health on a blog. When I looked at the two side by side, I was floored: every time my period was due, my mental health plummeted. Everything matched up. In 2016, aged 26, I was officially diagnosed with PMDD.

It was thought that the hormone progesterone was sending me haywire, so I was put on a three-month trial of oestrogen-only hormone therapy, which suppresses the menstrual cycle.

Different treatments work for different people, but hormone therapy worked for me. The doctors then put me on a temporary chemical-induced menopause. It simulated what life would be like if I was to have a hysterectomy and my body stopped naturally producing progesterone. It was the best three months of my life. I didnt have a single down day. In disbelief, I made a bucket list, determined to reclaim my life. They were minor things to most people, like going to Planet Hollywood and the hot-air Balloon Fiesta in Bristol, and visiting the Leaning Tower Of Pisa. My best friend and I booked a four-day trip to Italy. Despite planning to come home if my mental health should plummet, there wasnt a single difficult moment. Gazing up at the Leaning Tower Of Pisa on my first holiday in five years, I breathed in the warm Italian air. Then and there, I decided that I couldnt go back to life as it was before.

One afternoon, two years after my diagnosis, my doctors broke something to me. The chemical menopause that had brought me so much bliss wasnt a long-term solution because denying your body progesterone completely for an extended period of time can cause dangerous abnormal cell growth. Doctors told me I should consider having a full hysterectomy, removing my uterus, ovaries and fallopian tubes. While less invasive methods work for many other people with PMDD, sadly I was at the end of the treatment plan and this was the only option I had left.

All the way home, I juggled the two options in my mind: did I really want a future where I couldnt have my own child? Id wanted to have a family ever since I was little. How would my mum feel? Shed always wanted grandkids. But that night, chatting things through with her, I realised that the PMDD would eventually mean she would lose me. It had caused me to self-destruct. I couldnt keep putting my family and friends through overdoses. How could I have a child when I couldnt even care for myself?

My hysterectomy was booked for 7th May 2019. It was a gorgeous late spring day and I woke early, feeling galvanised and strong. This was going to be the first day of the rest of my life. But still, a seed of doubt niggled: was I doing the right thing? What if it didnt work? Mum and Dad came with me, and I had packed my overnight bag with a fluffy uterus draped in a superman cape that my mates had given me for good luck. I wore a T-shirt emblazoned with See you later, ovulator, and on the way to the hospital, Christina Aguileras Fighter blared from the car stereo.

The procedure lasted two and a half hours. I was given an epidural and a general anaesthetic, and had keyhole surgery. When I woke up, I was woozy and couldnt feel my legs, but I couldnt believe it had actually happened. Mum and Dad were there to greet me. I stayed in hospital for two nights and made such a good recovery, physically and mentally, that on the day that I was discharged, I joined my friends at the pub.

Since the hysterectomy, I am living the life I always wanted, but never felt was possible. Every single one of my PMDD symptoms has vanished. I can now picture the future owning a house and having children; things, until now, Ive never been stable enough to seriously imagine. I have frozen my eggs and I would like to try surrogacy, but expenses and fertility-clinic costs total around 30,000, so Im not sure thats an option. My dream is to foster or adopt one day whether Im in a relationship or not. I havent even thought about dating.

Of course, the hysterectomy cant erase the pain Ive been through. It cant give me back the lost years I spent detached from friends or unable to nurture a stable relationship, the many nights I lay sobbing under my duvet or the hurt I caused myself and those I love. Now, though, the eating disorder that plagued my life for years has disappeared, and I havent self-harmed since my surgery. The operation set me free. Ill have hormone-replacement therapy for life, but its a small price to pay for having my world back. Many women who suffer from PMDD take their own lives. I could have been one of them.

I threw a hysterectomy party to celebrate the procedure. As my friends and I played pin the egg on the uterus and had strawberry Baileys shots out of syringes, I caught sight of myself laughing. It felt like the first time Id done it in years.

Know the symptoms

They could be emotional, like mood swings, feeling overwhelmed and suicidal thoughts, or physical ones, such as breast tenderness, sleep problems and headaches. Typically you will only experience symptoms for a week or two before a period, but its different for everyone. Find a full list of symptoms at Mind.org.uk.

Keep a diary

Your doctor may ask you to keep a detailed record of symptoms for several months. If you feel they arent taking you seriously, do this yourself you can download mood charts from the internet to help you.

Consider finding an advocate

They can come to appointments to help make sure people listen to you. It can be a friend or family member, or a professional advocate find more details at Mind.org.uk.

If youre experiencing suicidal feelings and are worried you may act on them, call 999, go straight to A&E or call Samaritans for free on 116 123 to talk.

For further help, Emily found support at Pms.org.uk

If you need support with your mental health, reach out to Mind for help and information.

This feature appeared in the July 2020 issue of Cosmopolitan, out now.

This commenting section is created and maintained by a third party, and imported onto this page. You may be able to find more information on their web site.

Original post:
Coping with PMDD, the crippling period condition - cosmopolitan.com

Posted in Hormone Replacement Therapy | Comments Off on Coping with PMDD, the crippling period condition – cosmopolitan.com

Coronavirus threat to global Healthcare Nanotechnology (Nanomedicine) Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type…

Posted: June 15, 2020 at 10:46 pm

The Healthcare Nanotechnology (Nanomedicine) Market research report enhanced worldwide Coronavirus COVID19 impact analysis on the market size (Value, Production and Consumption), splits the breakdown (Data Status 2014-2020 and 6 Year Forecast From 2020 to 2026), by region, manufacturers, type and End User/application. This Healthcare Nanotechnology (Nanomedicine) market report covers the worldwide top manufacturers like (Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International) which including information such as: Capacity, Production, Price, Sales, Revenue, Shipment, Gross, Gross Profit, Import, Export, Interview Record, Business Distribution etc., these data help the consumer know about the Healthcare Nanotechnology (Nanomedicine) market competitors better. It covers Regional Segment Analysis, Type, Application, Major Manufactures, Healthcare Nanotechnology (Nanomedicine) Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Healthcare Nanotechnology (Nanomedicine)[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2041239

Healthcare Nanotechnology (Nanomedicine) Market report offers comprehensive assessment of 1) Executive Summary, 2) Market Overview, 3) Key Market Trends, 4) Key Success Factors, 5) Healthcare Nanotechnology (Nanomedicine) Market Demand/Consumption (Value or Size in US$ Mn) Analysis, 6) Healthcare Nanotechnology (Nanomedicine) Market Background, 7) Healthcare Nanotechnology (Nanomedicine) industry Analysis & Forecast 20202026 by Type, Application and Region, 8) Healthcare Nanotechnology (Nanomedicine) Market Structure Analysis, 9) Competition Landscape, 10) Company Share and Company Profiles, 11) Assumptions and Acronyms and, 12) Research Methodology etc.

Scope of Healthcare Nanotechnology (Nanomedicine) Market:It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Anticancer CNS Product Anti-infective Other

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Nanomedicine Nano Medical Devices Nano Diagnosis Other

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2041239

Geographically, the report includes the research on production, consumption, revenue, Healthcare Nanotechnology (Nanomedicine) market share and growth rate, and forecast (2020-2026) of the following regions:

Important Healthcare Nanotechnology (Nanomedicine) Market Data Available In This Report:

Strategic Recommendations, Forecast Growth Areasof the Healthcare Nanotechnology (Nanomedicine) Market.

Challengesfor the New Entrants,TrendsMarketDrivers.

Emerging Opportunities,Competitive Landscape,Revenue Shareof Main Manufacturers.

This Report Discusses the Healthcare Nanotechnology (Nanomedicine) MarketSummary; MarketScopeGives A BriefOutlineof theHealthcare Nanotechnology (Nanomedicine) Market.

Key Performing Regions (APAC, EMEA, Americas) Along With Their Major Countries Are Detailed In This Report.

Company Profiles, Product Analysis,Marketing Strategies, Emerging Market Segments and Comprehensive Analysis of Healthcare Nanotechnology (Nanomedicine) Market.

Healthcare Nanotechnology (Nanomedicine) Market ShareYear-Over-Year Growthof Key Players in Promising Regions.

What is the (North America, South America, Europe, Africa, Middle East, Asia, China, Japan)production, production value, consumption, consumption value, import and exportof Healthcare Nanotechnology (Nanomedicine) market?

To Get Discount of Healthcare Nanotechnology (Nanomedicine) Market:https://www.researchmoz.us/enquiry.php?type=D&repid=2041239

Contact:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

View original post here:
Coronavirus threat to global Healthcare Nanotechnology (Nanomedicine) Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type...

Posted in Nano medicine | Comments Off on Coronavirus threat to global Healthcare Nanotechnology (Nanomedicine) Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type…

Kanazawa University Research: Cell Removal as the Result of a Mechanical Instability – PR Newswire UK

Posted: June 15, 2020 at 10:46 pm

KANAZAWA, Japan, June 15, 2020 /PRNewswire/ -- Researchers at Kanazawa University report in the Biophysical Journal that the process of cell removal from an epithelial layer follows from an inherent mechanical instability. Moreover, the forces generated by an extruding cell can drive the extrusion of other cells in a particular direction.

The outer or inner boundaries of organs in the human body are lined with so-called epithelial sheets. These are layers of epithelial cells that can individually change their 3D shape which is what happens during biological processes like organ development (morphogenesis), physiological equilibrium (homeostatis) or cancer formation (carcinogenesis). Of particular interest is the process of cell extrusion, where a single cell loses its 'top' or 'bottom' surface and is subsequently pushed out of the layer. A thorough understanding of this phenomenon from a mechanical point of view has been lacking, but now, Satoru Okuda and Koichi Fujimoto from Kanazawa University have discovered that there is a purely mechanical cause for cell extrusion.

Mechanically speaking, a simple (single-layer) epithelial sheet is analogous to a foam, and can be represented as a layer of interconnected polyhedra.Okuda and Fujimoto used such a foam model to describe a monolayer of epithelial cells, with each cell a polyhedron with average volume V. Every cell is further characterized by the number of neighboring cells n, the area of the apical ('top') and the area of the basal ('bottom') surface.The model, taking into account mechanical forces between neighboring cells, leads to a formula for the total mechanical energy of an epithelial sheet as a function of only a few parameters, including V and n, as well as the in-plane density and a quantity called sharpness, which can distinguish between situations where basal and/or apical surfaces are present or not. (A vanished apical surface implies basal extrusion and vice versa.) By studying how the energy changes by varying these few parameters, the researchers were able to obtain valuable insights into the mechanics of an epithelial sheet.

The key finding of Okuda and Fujimoto is that the system exhibits an inherent mechanical instability: small changes in cell topology or cell density can cause cell extrusion without additional forces being applied.Furthermore, it turns out that a cell undergoing extrusion generates forces within the layer, which can direct the extrusion of other cells to either side of the layer.

The scientists also found many agreements between the outcomes of their model and observations in living systems, such as the occurrence of different epithelial geometries (e.g. 'rosette' or pseudostratified structures).

The model admittedly has limitations, for example the assumptions that the whole sheet and the individual cell surfaces are not curved but flat. However, quoting the researchers, "despite its limitations, [the] model provides a guide to understanding the wide range of epithelial physiology that occurs in morphogenesis, homeostasis, and carcinogenesis".

BackgroundEpithelial cells

Epithelial tissue, one of four kinds of human (or animal) tissue, is located on the outer surfaces of organs and blood vessels in the human body, and on the inner surfaces of 'hollow spaces' in various internal organs. A typical example is the outer layer of the skin, called the epidermis. Epithelial tissue consists of epithelial cells; it can be just one layer of epithelial cells (simple epithelium), or two or more (layered or stratified epithelium). Satoru Okuda and Koichi Fujimoto from Kanazawa University have now modeled a simple epithelium as an arrangement of polyhedra in order to study its mechanical properties and specifically the process of epithelial cell extrusion.

Cell extrusion

In epithelial tissue, cell extrusions happen the processes whereby epithelial cells are 'pushed out' of the epithelium. Cell extrusion is an important biological process, regulating for example the removal of apoptotic (dead) cells, tissue growth and the response to cancer. Okuda and Fujimoto looked at a simple epithelium from a mechanical point of view. Modeling the epithelium as a layer of interconnected polyhedra, they found that cell extrusion whereby the top or bottom surface of a polyhedron shrinks to a point and then vanishes can be considered a purely mechanical property. An inherent instability, present in homogeneous sheets, can lead to cells being extruded due to small changes in density or topology.

Reference

Satoru Okuda, and Koichi Fujimoto. A Mechanical Instability in Planar Epithelial Monolayers Leads to Cell Extrusion, Biophysical Journal 118, 2549 (2020).

DOI: 10.1016/j.bpj.2020.03.028

URL: https://doi.org/10.1016/j.bpj.2020.03.028

About Nano Life Science Institute (WPI-NanoLSI) https://nanolsi.kanazawa-u.ac.jp/en/

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology. The objective of this initiative is to form world-tier research centers. NanoLSI combines the foremost knowledge of bio-scanning probe microscopy to establish 'nano-endoscopic techniques' to directly image, analyze, and manipulate biomolecules for insights into mechanisms governing life phenomena such as diseases.

About Kanazawa University http://www.kanazawa-u.ac.jp/e/

As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949. The University has three colleges and 17 schools offering courses in subjects that include medicine, computer engineering, and humanities.

The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture. The city of Kanazawa has a highly respected intellectual profile since the time of the fiefdom (1598-1867). Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Contact :Hiroe Yoneda Vice Director of Public Affairs WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University Kakuma-machi, Kanazawa 920-1192, Japan Email: nanolsi-office@adm.kanazawa-u.ac.jp Tel: +81-76-234-4550

SOURCE Kanazawa University

Visit link:
Kanazawa University Research: Cell Removal as the Result of a Mechanical Instability - PR Newswire UK

Posted in Nano medicine | Comments Off on Kanazawa University Research: Cell Removal as the Result of a Mechanical Instability – PR Newswire UK

Impact of Covid-19 on Nano Chemotherapy Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Dell Wyse, IBM, Microsoft -…

Posted: June 15, 2020 at 10:46 pm

Industry Overview ofNano Chemotherapy Market:The research report titled, Nano Chemotherapy has adopted a systematic way to evaluate the dynamics of the overall market. It gives a definite study comprising a top to bottom research on the markets growth drivers, challenges, threats, and potential lucrative opportunities, with a key focus on global. In a chapter-wise format, the report assesses the demand and supply trends witnessed in the overall market, complete with important insights and graphical representation. An in-depth investment feasibility analysis and market attractiveness analysis is provided in the report, which makes it a miscellaneous document for players operating in the worldwide market.

Understand the influence of COVID-19 on the Nano Chemotherapy Market Size with our analysts monitoring the situation across the globe.

The novel COVID-19 pandemic has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. This report presented by Garner Insights contains a thorough analysis of the pre and post pandemic market scenarios. This report covers all the recent development and changes recorded during the COVID-19 outbreak..

Access PDF Sample Copy of the Report, With 30 mins free consultation! Click here@https://garnerinsights.com/Global-Nano-Chemotherapy-Market-Size-Status-and-Forecast-2020-2026#request-sample

The research report additionally provides crucial data about the Nano Chemotherapy market overview, scope, and future viewpoint. The report additionally speaks about the market dynamics and the competitive landscape of the worldwide Nano Chemotherapy market for the mentioned forecast period of 2018 to 2026. The report is the consequence of an in-depth market research carried out with the assistance of the industry specialists. The report likewise gives data the key market players plying their trade in the global market.

The Global Nano Chemotherapy Market research report displays the market size, status, share, production, cost analysis, and market value with the forecast period 2018-2026. Other than that, upstream raw materials, downstream demand analysis, consumption volume, and the market share by segments and sub-segments have also been discussed. The research methodology of the market is based on both primary as well as secondary research data sources. It commits different factors affecting Nano Chemotherapy industry such as market environment, different policies of the government, historical data and market trends, technological advancements, forthcoming innovations, market risk factors, market restraints, and obstacles in the industry.

Major Key Players of the Nano Chemotherapy Market are:

Dell Wyse,IBM,Microsoft,Hewlett-Packard (HP),Amazon,Cisco Systems,Citrix,VMware,Rackspace,MokaFive,NComputing,

Major Types of Nano Chemotherapy covered are:

Medicine Therapy,Physical Therapy,Other,

Major Applications of Nano Chemotherapy covered are:

Hospitals,Clinics,Other,

To understand the competitive scenario of the market, an analysis of the Porters Five Forces model has also been included for the market. The research also includes a market attractiveness analysis, in which all the segments are highlighted on the basis of their market share, size, growth rate, and overall attractiveness. This market research is conducted leveraging the data sourced from the primary and secondary research team of industry professionals as well as the in-house databases. Research analysts and consultants cooperate with the key organizations of the concerned domain to verify every value of data exists in this report.

The answers to the following key questions can be found in the report:What are the key reasons to focus on this particular market?

Get Discount on this Report: https://garnerinsights.com/Global-Nano-Chemotherapy-Market-Size-Status-and-Forecast-2020-2026#discount

The report magnifies Nano Chemotherapy market competitors by exploring their newly adopted technological advancements, strategical and tactical business planning, business expansions, acquisitions, partnerships, and new product launches that gives an absolute acuity of rivalry in the Nano Chemotherapy market.The report implements various analytical tools including SWOT analysis, Porters Five Forces analysis, and Capacity Utilization analysis to render a validated evaluation of the Nano Chemotherapy market. It also comprehends futuristic business opportunities, scope as well as market threats, challenges, barriers, obstacles, and regulatory framework to give a profound idea about the Nano Chemotherapy market that aids reader to form own business stratagem accordingly to meet their resolved business goals.

Contact Us:Kevin ThomasContact No: +1 513 549 5911 (US)+44 203 318 2846 (UK)sales@garnerinsights.com

See the rest here:
Impact of Covid-19 on Nano Chemotherapy Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Dell Wyse, IBM, Microsoft -...

Posted in Nano medicine | Comments Off on Impact of Covid-19 on Nano Chemotherapy Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Dell Wyse, IBM, Microsoft -…

Anesthesia may work by targeting the fat in our brains – Live Science

Posted: June 15, 2020 at 1:48 am

After nearly 150 years, we may finally understand how general anesthesia makes us drift into unconsciousness although some of the specifics remain murky.

These drugs dislodge molecules held in the fatty membrane that surrounds brain cells. Once the drugs reach this fatty shell, the freed molecules bounce around like billiard balls within the membrane and alter the function of proteins embedded in its surface, according to a new study in cultured cells and fruit flies.

The new findings could help resolve a mystery that has lingered for decades.

Related: From dino brains to thought control 10 fascinating brain findings

"People have been seriously hammering on this for at least 100 years," said study author Scott Hansen, an associate professor in the departments of molecular medicine and neuroscience at The Scripps Research Institute in La Jolla, California.

But not everyone thinks the new study can reveal why anesthetics put humans "to sleep."

"Let's just say there's a large difference between the fruit fly brain and the human brain," said Dr. Emery Brown, a professor of Medical Engineering and Computational Neuroscience at the Massachusetts Institute of Technology and a professor of Anaesthesia at Harvard Medical School, who was not involved in the study.

Since dental surgeon Dr. William Morton first used the chemical ether as an anesthetic in the 1840s, scientists have sought to understand how the drug and other anesthetics interact with the brain. Nineteenth-century scientists suspected that anesthetics somehow disrupted the fatty membrane surrounding cells, including brain cells, as the drugs repel water while readily mixing with oils and fats, he said. Later research, conducted in the 1980s, suggested that anesthetics bind directly to proteins lodged inside the fatty membrane and directly interfere with the activity of said proteins, driving down the overall activity of brain cells, The Scientist reported. But Hansen and his colleagues suspected this wasn't the whole story.

In experiments in cultured cells and fruit flies, the authors found that anesthetics disrupt specific pockets of fat within the cellular membrane; those disruptions then free molecules and trigger chain reactions elsewhere on the cell surface. The authors posit that these molecular changes, among other mechanisms, caused fruit flies to lose consciousness, as evidenced by the insects becoming immobile for several minutes.

However, experts told Live Science that these animal experiments can only tell us so much about how the drugs work in humans.

While the study reconfirms that anesthetics are "dirty drugs," meaning they target multiple cellular systems at once, it cannot say exactly how disruptions to the fatty membrane alter consciousness, or even how those changes alter activity throughout the brain, Brown told Live Science.

The drugs disrupt the membrane, "okay, but now finish the story," he said. "How does that then drive [activity in] certain parts of the brain?" Understanding how anesthetics work could help doctors use the drugs more precisely in the clinic, Brown said.

This understanding might also hint at how the brain naturally shifts in and out of consciousness, as it does during sleep, Hansen added.

"Back in the day," when anesthetics first entered widespread use, scientists theorized that many of the physiological effects of drugs stemmed from changes to the fatty membrane of cells, a gateway that determines when molecules may enter or exit, said Francisco Flores, a research scientist and instructor in the Anesthesia Department at Massachusetts General Hospital who was not involved in the study. As technology progressed, scientists discovered that many drugs interact with specific proteins anchored in the fatty membrane, and subsequently, research efforts focused more on these membrane-bound proteins than the fats surrounding them, known as lipids, he said.

"However, for anesthetics, the lipid hypothesis survived for longer," Flores said. Anesthetics can cross the blood-brain barrier, a border of cells that separates circulating blood from brain tissue and allows only certain molecules to pass through. All anesthetics, as well as other drugs that pass the blood-brain barrier, repel water and readily interact with lipids, "so there's still a chance that they can do something in the membrane," he said.

But nineteenth-century scientists could not observe how anesthetics warped the lipid membrane; the task required superresolution microscopes that had not been invented at the time, Hansen said. Hansen and his co-authors used such a microscope, called dSTORM, to observe how cells reacted when bathed in the anesthetics chloroform and isoflurane.

Related: 10 facts every parent should know about their teen's brain

They found that different types of fats within the cell membrane reacted differently to the drugs.

One pocket of fats, known as GM1, contains high concentrations of cholesterol molecules, tightly packed together and dotted with specific sugar molecules. Upon exposure to anesthetic, the fats within these GM1 clusters spread out, and in doing so, release various proteins that were enmeshed with them. One such protein, called PLD2, escapes to a different bundle of fats and initiates a series of chemical reactions.

Specifically, the reaction opens a tunnel through the cell called a TREK1 ion channel, which allows positively charged particles to exit the cell. In a brain cell, this mass exodus of positive particles makes the cell more negatively charged and could suppress that cell's electrical and chemical activity. That, theoretically, could push the brain into an unconscious state, Hansen said.

But it may not be that straightforward, Brown noted.

To see if their cell experiments carried over to animals, the authors dissected the brains of fruit flies and found that, after exposure to chloroform, fats within the lipid membranes of the flies' brain cells spread out just as had been observed in cell culture. In addition, mutant fruit flies without the ability to make PLD2 became resistant to the chloroform treatment and required a larger dose to become sedated, researchers reported in the study, which was published May 28 in the journal Proceedings of the National Academy of Sciences.

Because the mutant flies were not completely immune to chloroform, the authors concluded that multiple mechanisms likely allow the drug's anesthetic effect to take hold. Disruptions to cells' lipid membrane may contribute to this overall effect, but at this point, their relative influence remains unclear, Brown noted. "Dirty" anesthetics trigger a number of reactions in the brain through different chemical and metabolic pathways, and scientists don't yet know how membrane disruptions affect the overall activity within that circuitry, he said.

These interactions will be difficult to untangle in the somewhat-simple fly brain, and even more challenging to understand in the human brain, Brown said.

That said, Hansen and his co-authors hypothesize that membrane disruptions may play a broader, unsung role in the effects of anesthetics on humans. Theoretically, anesthetics may indirectly affect many proteins by first disrupting the lipid membrane, Hansen said. Many proteins lodged in the lipid membrane have fatty acids stuck to their structures, for instance, and some of these proteins interact with brain chemicals and help drive activity of brain cells. One hypothesis is that if anesthetics target the fatty acids attached to these proteins, the drugs could conceivably alter their function and sedate the brain, Hansen said.

"Again, this is speculative," and would need to be confirmed with future studies, he added. Similar studies should be done with other drugs that cross the blood-brain barrier, not just anesthetics, to determine whether the effect appears unique or common to many classes of drug, Flores said. Hansen said he wants to see whether chemicals with similar effects already exist in the brain, and perhaps help put us to sleep.

While the new study opens many interesting avenues for future research, for now, the results remain fairly preliminary, Brown said.

"Do I do something different in the operating room now that I've read that paper? No," Brown said.

Originally published on Live Science.

Read the original post:
Anesthesia may work by targeting the fat in our brains - Live Science

Posted in Molecular Medicine | Comments Off on Anesthesia may work by targeting the fat in our brains – Live Science

Rheumatoid Arthritis Drug Could Be Repurposed To Treat COVID-19 Patients – Technology Networks

Posted: June 15, 2020 at 1:48 am

Lab tests and clinical pilot study

In test tubes and 3D-human miniature livers, the researchers showed that the drug inhibited signaling of cytokines, immune system-proteins known to overreact and drive inflammation in severe cases of COVID-19 infection. It also helped reduce the viral load of SARS-CoV-2, the virus that causes COVID-19, and the level of the signal molecule interleukin-6 (IL-6), a predictor of mortality from acute respiratory distress syndrome associated with COVID-19.

In addition to the lab tests, a small pilot study of three men and one woman with bilateral COVID-19 pneumonia was conducted in Milan, Italy. After 10-12 days of treatment with baricitinib, all four patients showed improvements in signs and symptoms such as cough, fever and reductions in viral load and plasma IL-6 levels.

Collectively, these data suggest that baricitinib may lower inflammation and viral load in COVID-19, says Ali Mirazimi, adjunct professor in the Department of Laboratory Medicine, Karolinska Institutet, who led the functional virus studies.

Additional trials of baricitinib are currently underway in 85 hospitalized COVID-19 patients across three hospitals in Northern and Central Italy, with encouraging initial results in patient outcomes, according to the researchers.

We are integrating and carefully analyzing these trial data and providing functional and mechanistic follow-up studies to scrutinize baricitinibs mode of action, says Volker Lauschke, associate professor of personalized medicine and drug development at the Department of Physiology and Pharmacology, Karolinska Institutet, who led the functional testing of baricitinib.

The study was funded by Eli Lilly and Company and the Sacco Baricitinib Study Group. Several of the authors reported potential conflicts of interests, including employment and shareholdings in Eli Lilly and Company, which owns the trademark for the baricitinib drug Olumiant. For a full list of disclosures, please see the full article.

Reference:Stebbing, et al. (2020) Mechanism of Baricitinib Supports Artificial Intelligence-Predicted Testing in COVID-19 Patients. EMBO Molecular MedicineDOI:10.15252/emmm.202012697

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Original post:
Rheumatoid Arthritis Drug Could Be Repurposed To Treat COVID-19 Patients - Technology Networks

Posted in Molecular Medicine | Comments Off on Rheumatoid Arthritis Drug Could Be Repurposed To Treat COVID-19 Patients – Technology Networks

Din College researchers believe more reasons behind high Covid-19 Cases on Navajo – Navajo-Hopi Observer

Posted: June 15, 2020 at 1:48 am

TSAILE, Ariz. A research paper authored by two Din College science professors about the coronavirus (COVID-19) pandemic and its impact upon Native Americans provides clarification of the transmission and virulence of the virus, the professors say.

The paper, The Medical Basis for Increased Susceptibility of COVID-19 among the Navajo and other Indigenous Tribes: A Survey, was written by Dr. Joseph DeSoto and Dr. Shazia Tabassum Hakim.

The paper concludes, in part, that ethnic and anatomic expression patterns of angiotensin converting enzyme 2 (ACE2) and associated pathophysiology suggests that Native Americans and Asians may be particularly susceptible to this disease (Covid-19).

It was submitted April 30 and accepted for publication May 29 in the Journal of Biomedical Research and Reviews. DeSoto and Hakim said the document represents the first comprehensive world-wide scientific understanding of the high rate of infectivity among the Navajo and Indigenous tribes of the SAR-CoV-2 from a molecular medical perspective on Covid-19.

Angiotensin Converting Enzyme 2 (ACE2) is a type of protein found on the surface of a number of cells in the respiratory, digestive, nervous and reproductive systems. The protein, in general, serves as a door where the virus enters the cells, the team explained.

And the key that the virus has is to open the door is a spike with the protein S, Hakim stated. When this right key S is inserted into the door lock (ACE-2), the magic happens and the virus enters the host cell, hijacks the host cells DNA machinery and starts producing its own proteins, multiplies, increases in number and infects more cells of the host body.

There are four things that aggravate COVID-19 as it pertains to the Navajo Nation, De Soto said. Medically, its the high rate of diabetes, hypertension, genetics and poor protein diets among the Navajo; poor health care infrastructure and technology; poverty, with the associated lack of water access; and dense multi-generational living arrangements.

The two professors work in the Science, Technology, Engineering and Math (STEM) division of the Din College. They said in December they had started talking amongst themselves about the causes of COVID-19, and then started reviewing the literature.

Late in December 2019, we read every single thing that was published out there in the scientific community, DeSoto said. We discussed it and evaluated it long before the virus came over here. Then based on the best medical evidence, we realized that this might soon be a problem. So, we started discussing, evaluating and analyzing and then we wrote and completed the paper.

Two more papers are being published within weeks in major peer reviewed Medical and Scientific Journals by De Soto and Hakim, The Medical Treatment for COVID-19, and with Dr. Fred Boyd, of Din College, a well-known molecular physiologist, The Pathophysiology of COVID-19, both of which have already received international attention via preprints.

The Navajo Nation has the highest COVID-19 rate in the United States which is 450% higher than the national average.

DeSoto, who was senior author and is a medical school graduate of Howard University. His specialty is molecular medicine and pharmacogenetics. Hakim has a background in microbiology and infectious diseases. She is a graduate of the University of Karachi in Pakistan.

Hakim said she and DeSoto are working on another manuscript related to the eating habits, food scarcity and the unavailability of the varieties of fruits and vegetables in Navajo communities.

The Journal of Biomedical Research and Review is an international, peer reviewed, open access, scientific and scholarly journal which publishes research papers, review papers, mini reviews, case reports, case studies, short communications, letters, editorials, books, theses and dissertations from various aspects of medicine, engineering, science and technology to improve and support health care.

Information provided by Din College

More:
Din College researchers believe more reasons behind high Covid-19 Cases on Navajo - Navajo-Hopi Observer

Posted in Molecular Medicine | Comments Off on Din College researchers believe more reasons behind high Covid-19 Cases on Navajo – Navajo-Hopi Observer

Page 971«..1020..970971972973..980990..»